Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

Treatment with both upadacitinib or adalimumab demonstrated improvement in pain scores vs placebo at weeks 2, 12, and 26. Upadacitinib (UPA) may offer superior pain management for patients with ...

One-third of patients with rheumatoid arthritis had unacceptably high levels of pain 5 years after diagnosis, often despite low levels of inflammation, Swedish researchers found. In an inception ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Arthritis is a complex and often misunderstood condition that affects millions of individuals worldwide. It is not a single disease but rather an umbrella term that encompasses over 100 types of joint ...

An estimated 1.5 million Americans have a rheumatoid arthritis diagnosis, according to the Arthritis Foundation. Many patients with the autoimmune illness experience flare-ups and chronic pain. But ...

Treating rheumatoid arthritis (RA) typically means taking drugs to address the inflammatory process that leads to joint pain in RA. These drugs may be taken by mouth, or by injection or infusion. But ...

Nearly half of the patients with rheumatoid arthritis (RA) in sustained clinical and ultrasound remission still report unacceptable pain, with women experiencing higher pain levels than men. Patient ...

Rheumatoid arthritis (RA) is a painful joint condition that affects about 1.5 million people in the United States. Pain, tenderness, and stiffness are often the first symptoms of RA and can affect ...

More than just a condition that causes achy joints, rheumatoid arthritis (RA) is a chronic inflammatory disorder that can affect a person’s life in profound ways. People with RA seesaw between periods ...